Cortica, a provider for autistic and neurodivergent children, has secured $80 million in funding co-led by Morgan Health and Nexus NeuroTech Ventures to expand its value-based care contracts and services across eight states. The investment aims to enhance evaluation, diagnosis, and treatment while improving clinical outcomes, addressing the growing demand for integrated care solutions. Cortica's model, which includes a multidisciplinary team, has shown to reduce therapy volumes and associated costs while improving patient outcomes.
